This document discusses kinetics and drug stability. It defines chemical kinetics as the study of reaction rates and explains how it applies to changes in drugs and formulations over time. It also covers the rates and orders of reactions, including zero-order, first-order, and mixed-order kinetics. Factors that can affect reaction rates like temperature, light, and solvents are identified. The document discusses complex reactions and strategies for stability testing and predicting a drug's shelf life.
The presentation concisely describes the different pharmacokinetic parameters and basics of compartment modelling. It will help undergraduate students to understand the basic concepts of Biopharmaceutics.
Concept of rate of reaction.
Factors effecting rate of reaction.
Concept of order of reaction.
Methods for the determination of order of reaction.
Pharmaceutical importance and applications of rate and order of reaction.
Chapter of M pharm First semester, Which covers order and rate of reaction,first order and zero order kinetics , ICH guidelines for stability testing,Storage conditions,etc.
The presentation concisely describes the different pharmacokinetic parameters and basics of compartment modelling. It will help undergraduate students to understand the basic concepts of Biopharmaceutics.
Concept of rate of reaction.
Factors effecting rate of reaction.
Concept of order of reaction.
Methods for the determination of order of reaction.
Pharmaceutical importance and applications of rate and order of reaction.
Chapter of M pharm First semester, Which covers order and rate of reaction,first order and zero order kinetics , ICH guidelines for stability testing,Storage conditions,etc.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
How many patients does case series should have In comparison to case reports.pdfpubrica101
Pubrica’s team of researchers and writers create scientific and medical research articles, which may be important resources for authors and practitioners. Pubrica medical writers assist you in creating and revising the introduction by alerting the reader to gaps in the chosen study subject. Our professionals understand the order in which the hypothesis topic is followed by the broad subject, the issue, and the backdrop.
https://pubrica.com/academy/case-study-or-series/how-many-patients-does-case-series-should-have-in-comparison-to-case-reports/
Leading the Way in Nephrology: Dr. David Greene's Work with Stem Cells for Ki...Dr. David Greene Arizona
As we watch Dr. Greene's continued efforts and research in Arizona, it's clear that stem cell therapy holds a promising key to unlocking new doors in the treatment of kidney disease. With each study and trial, we step closer to a world where kidney disease is no longer a life sentence but a treatable condition, thanks to pioneers like Dr. David Greene.
Health Education on prevention of hypertensionRadhika kulvi
Hypertension is a chronic condition of concern due to its role in the causation of coronary heart diseases. Hypertension is a worldwide epidemic and important risk factor for coronary artery disease, stroke and renal diseases. Blood pressure is the force exerted by the blood against the walls of the blood vessels and is sufficient to maintain tissue perfusion during activity and rest. Hypertension is sustained elevation of BP. In adults, HTN exists when systolic blood pressure is equal to or greater than 140mmHg or diastolic BP is equal to or greater than 90mmHg. The
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Medical Technology Tackles New Health Care Demand - Research Report - March 2...pchutichetpong
M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028.
According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.”
There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation.
The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs.
In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.
2. CONTENTS
• Introduction
• Rates and order of reaction
• Method for determining the order of reaction
• Complex reaction
• Factor affecting rate of reaction
• kinetics of drugs decompositions
2/7/2016 2
vignan pharmacy college
3. Drugs stability is defined as the pharmaceutical dosages form
to maintain the physical, chemical, therapeutic and microbial
properties during the time of storage and uses by the patient.
Stability is defined as the capacity of a drugs substance to
remain within the established specification to maintain its
identity, strength, quality and purity throughout the retest or
expiration during period.
Definition
kinetics & Drug stability
2/7/2016 vignan pharmacy college 3
4. Chemical kinetics is the study of rate of chemical changes
taking place during chemical reaction.
As applied to pharmaceutical formulation , this include a study
of physical and chemical changes in drugs and dosage form,
factor influencing the rate of these chemical reaction, accelerated
stability testing and prediction of shelf life.
2/7/2016 vignan pharmacy college 4
5. RATES AND ORDER OF REACTION
The velocity with which a reaction or a process occurs is
called as its rate, concentration of drugs influences the rate of
reaction or process is called as the order of reaction or order
of process.
Consider the following chemical reaction
Drug A Drug B
2/7/2016 5
vignan pharmacy college
6. The rate of forward reaction is expressed as :
-dA/dt
-ve sign = concentration of drugs A decreases with time.
As the reaction proceeds, the concentration of the drugs B
increases and the rate of reaction can also be expressed as:
dB/dt
Experimentally, the rate of reaction is determined by
measuring the decrease in concentration of drugs A with
time.
2/7/2016 vignan pharmacy college 6
7. If c is the concentration of drug A, the rate of decrease in c of
drug A as it is changed to B can be described by expression as
function of time t.
dC/dt = -kc
Where,
k= rate constant
n=order of reaction
If,
n= 0 (zero order process)
n= 1 (first order process)
2/7/2016 vignan pharmacy college 7
8. The order of a reaction determines the way in which the
concentration of a reactant or reactants influences the rate of a
chemical reaction.
Molecularity of Reaction
The molecularity of a reaction refers to the numbers of
molecules, atoms, or ions reacting in a elementary process
to give the reactants.
If only one type of molecules undergoes a change in to
yield the product , the product is said to be unimolecular.
2/7/2016 8
vignan pharmacy college
9. If two molecules undergoes to change yield the product,
the reaction is said to be bimolecular.
Reaction that involves more than one steps ( complex
reaction) may have different molecularity and order of
reaction.
The three commonly encountered rate process:
Zero order reaction
First order reaction
Mixed order reaction
2/7/2016 9
vignan pharmacy college
10. Zero-order kinetics
o Its is also called as constant rate process.
o The reaction is said to be zero-order reaction , if the rate of
reaction is independent of the concentration i.e. the rate of
reaction can not be increased further by increasing the
concentration of reactants.
dc/dt= -KoCo = -Ko equation.....1
Where
Ko = zero-order rate constant (in mg/min)
2/7/2016 10
vignan pharmacy college
11. Rearrangement of equation 1 yields:
dc= -Ko dt equation..........2
Integration of equation 2 gives:
C - Co = - k0 t
where
Co = concentration of drug at t = 0, and
C = concentration of drug yet to undergo
reaction at time t.
2/7/2016 vignan pharmacy college 11
12. Fig. 1. Graphs of zero-order kinetics
2/7/2016 12
vignan pharmacy college
13. First-order kinetics
Whose rate is directly proportional to the concentration of the
of drugs undergoing reaction i.e. greater the concentration ,
faster the reaction.
First-order process is said to follow linear kinetics
C
K
dt
dC
Where
K = first-order rate constant (per hour)
2/7/2016 vignan pharmacy college 13
14. Fig. 2: Graph of first-order kinetics showing linear relationship
between rate of reaction and concentration of drug
2/7/2016 vignan pharmacy college 14
15. Mixed order kinetics
In some instances, the kinetics of a pharmacokinetic
process changes from predominantly first-order to
predominantly zero-order with increasing dose or chronic
medication.
A mixture of both first-order and zero-order kinetics is
observed in such cases and therefore the process is said to
follow mixed-order kinetics.
Since deviations from an originally linear pharmacokinetic
profile are observed, the rate process of such a drug is called
as nonlinear kinetics. 2/7/2016 vignan pharmacy college 15
16. Mixed order kinetics is also termed as dose-dependent kinetics as
it is observed at increased or multiple doses of some drugs.
Nonlinearities in pharmacokinetics have been observed in –
Drug absorption (e.g. vitamin C)
Drug distribution (e.g. naproxen), and
Drug elimination (e.g. riboflavin).
The kinetics of such capacity-limited processes can be
described by the Michaelis-Menten kinetics.
2/7/2016 16
vignan pharmacy college
17. Complex reaction
Many chemical reaction encountered in the pharmaceutical
field are not simple reaction of the zero, first, second or third
order but consists of a combination of two or more reaction .
such reaction is known as complex reaction.
Complex reaction may be classified as:
• Reversible reaction
• Parallel reaction
• Consecutive or series reaction
2/7/2016 vignan pharmacy college 17
18. Factor affecting rate of reaction
•Temperature
•Light
•Solvent
•Ionic strength
•Dielectric constant of solvents
•Catalysis
•Surfactants
2/7/2016 vignan pharmacy college 18
19. Kinetics of drugs decomposition
A drugs in suspension follows apparent zero order kinetics
in which the concentration of the drugs in the solution
remains constant with time.
When the drugs in the solution degrades or lost by any
means new drugs molecules from the suspended solid
particles dissolved in the solution to keep the concentration
constant at the equilibrium solubility.
That is the solid suspended particles act as reservoir of
drugs.
2/7/2016 19
vignan pharmacy college
20. Acid catalysed hydrolysis of the digoxin follows pseudo
first order reaction kinetics , here the concentration of H+
remains constant . Therefore the rate slowly depends on the
concentration of digoxin.
Hydrolysis of chlorbutanol in presence of sodium
hydroxide follows second order reaction.
2/7/2016 vignan pharmacy college 20
21. Strategy of stability testing
Strategy is important for the stability testing of any dugs to
maintain their shelf life .
To maintain the shelf life of drugs the ICH and WHO
guideline for stability testing should be followed.
Protection against hydrolysis
Protection against oxidation
2/7/2016 21
vignan pharmacy college
22. Accelerated stability analysis
Accelerated stability analysis is design to predict stability
and hence shelf life of formulation under normal and
recommended storage condition by carrying out the study
under accelerated condition of temperature, moisture and
light.
Prediction of shelf life
Shelf life is the time period during which the dosages
form is supposed to retain its original quantity.
The prediction is based on the arrhenius equation .
2/7/2016 vignan pharmacy college 22
23. Stability of solid dosages form
The decomposition of drugs in solid dosages form is
more complex than that occurring in the pure drugs.
The following are the effect of various factor on the
stability in solid dosages form:
Temperature
Moisture
Chemical interaction
2/7/2016 vignan pharmacy college 23
24. Types of stability studies
Long term stability studies
Accelerated stability studies
Testing frequency
Packaging and container
2/7/2016 vignan pharmacy college 24